Neoadjuvant Chemotherapy Not Superior to Upfront Surgery in Colon Cancer: JAMA
Researchers have found in a negative trial that neoadjuvant chemotherapy did not improve disease-free survival compared with upfront surgery. However, along with other phase III studies, the findings suggest it…